Madrigal Pharmaceuticals (MDGL) News
NASDAQ: MDGLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
471.75-5.16 (-1.08%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MDGL news summary
We found 1 recent headline mentioning Madrigal Pharmaceuticals (MDGL): 1 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, MDGL is down 1.08% at $471.75. The most recent story, "Can NVO's Semaglutide Push Create Growth Beyond Cardiometabolic Care?", was published by Nasdaq on Oct 7, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology